Skip to main content
FinSpry Logo
FinSpry
LPCN logo
LPCN
(NASDAQ)
Lipocine Inc.
$2.19-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Lipocine (LPCN) Stock Price & Financial Analysis

Lipocine Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$2.17 - $2.22
52-Week High$12.37
52-Week Low$1.81
Open$2.20
Volume21.83K
Average Volume (3M)71.38K
Market Cap14.88M
Shares Outstanding6.79M
Price to Sales (P/S)7.43
Price to Book (P/B)0.65
EV/EBITDA-0.84
Revenue (TTM)2.00M
Net Income (TTM)-11.43M
Free Cash Flow (TTM)-10.05M
EPS (TTM)$-1.97
Profit Margin-571.10%
Operating Margin-605.86%
Return on Equity (ROE)-50.08%
Debt to Equity0.00
50-Day MA$2.30
200-Day MA$4.62
52-Week Change-33.03%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Lipocine

What is the current stock price for LPCN?

As of the latest trading session, LPCN stock trades at $2.19. The 52-week range is $1.81–$12.37, with a day range of $2.17–$2.22.

What is the P/E ratio for LPCN?

The P/E ratio (Price-to-Earnings) for LPCN is shown in the Key Statistics section. This valuation metric helps compare Lipocine Inc. to industry peers.

Does LPCN pay dividends?

Lipocine does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for LPCN?

Analyst ratings and recommendations for LPCN are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.

What is the market cap of LPCN?

Lipocine's market capitalization is $14.9M, classifying it as a micro-cap company. Lipocine operates in the Healthcare sector within the Biotechnology industry.